Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8,035 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II Randomized Preoperative Window-of-Opportunity Study of the PI3K Inhibitor Pictilisib Plus Anastrozole Compared With Anastrozole Alone in Patients With Estrogen Receptor-Positive Breast Cancer.
Schmid P, Pinder SE, Wheatley D, Macaskill J, Zammit C, Hu J, Price R, Bundred N, Hadad S, Shia A, Sarker SJ, Lim L, Gazinska P, Woodman N, Korbie D, Trau M, Mainwaring P, Gendreau S, Lackner MR, Derynck M, Wilson TR, Butler H, Earl G, Parker P, Purushotham A, Thompson A. Schmid P, et al. Among authors: thompson a. J Clin Oncol. 2016 Jun 10;34(17):1987-94. doi: 10.1200/JCO.2015.63.9179. Epub 2016 Mar 14. J Clin Oncol. 2016. PMID: 26976426 Free PMC article. Clinical Trial.
Neoadjuvant treatment of breast cancer.
Thompson AM, Moulder-Thompson SL. Thompson AM, et al. Ann Oncol. 2012 Sep;23 Suppl 10(Suppl 10):x231-6. doi: 10.1093/annonc/mds324. Ann Oncol. 2012. PMID: 22987968 Free PMC article.
Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial.
Cuzick J, Sestak I, Forbes JF, Dowsett M, Knox J, Cawthorn S, Saunders C, Roche N, Mansel RE, von Minckwitz G, Bonanni B, Palva T, Howell A; IBIS-II investigators. Cuzick J, et al. Lancet. 2014 Mar 22;383(9922):1041-8. doi: 10.1016/S0140-6736(13)62292-8. Epub 2013 Dec 12. Lancet. 2014. PMID: 24333009 Free article. Clinical Trial.
Adverse surgical outcomes in screen-detected ductal carcinoma in situ of the breast.
Thomas J, Hanby A, Pinder SE, Ball G, Lawrence G, Maxwell A, Wallis M, Evans A, Dobson H, Clements K, Thompson A; Sloane Project Steering Group. Thomas J, et al. Among authors: thompson a. Eur J Cancer. 2014 Jul;50(11):1880-90. doi: 10.1016/j.ejca.2014.02.023. Epub 2014 May 26. Eur J Cancer. 2014. PMID: 24874088 Free article.
NEOCENT: a randomised feasibility and translational study comparing neoadjuvant endocrine therapy with chemotherapy in ER-rich postmenopausal primary breast cancer.
Palmieri C, Cleator S, Kilburn LS, Kim SB, Ahn SH, Beresford M, Gong G, Mansi J, Mallon E, Reed S, Mousa K, Fallowfield L, Cheang M, Morden J, Page K, Guttery DS, Rghebi B, Primrose L, Shaw JA, Thompson AM, Bliss JM, Coombes RC. Palmieri C, et al. Among authors: thompson am. Breast Cancer Res Treat. 2014 Dec;148(3):581-90. doi: 10.1007/s10549-014-3183-4. Epub 2014 Nov 14. Breast Cancer Res Treat. 2014. PMID: 25395314 Clinical Trial.
Viewpoint: Availability of oestrogen receptor and HER2 status for the breast multidisciplinary meeting discussion; time to get it right.
Francis A, Bartlett J, Rea D, Pinder SE, Stein RC, Stobart H, Purdie CA, Rakha E, Thompson A, Shaaban AM; Translational Subgroup of the NCRI Breast Clinical Studies Group. Francis A, et al. Among authors: thompson a. Eur J Surg Oncol. 2016 Jul;42(7):994-8. doi: 10.1016/j.ejso.2016.02.015. Epub 2016 Mar 16. Eur J Surg Oncol. 2016. PMID: 27020141
8,035 results